Evaluation of the change in sphingolipids in the human multiple myeloma cell line U266 and gastric cancer cell line MGC-803 treated with arsenic trioxide-Reference-Cited by-同舟云学术

Evaluation of the change in sphingolipids in the human multiple myeloma cell line U266 and gastric cancer cell line MGC-803 treated with arsenic trioxide

Published:2015-11 Issue: Volume:1004 Page:98-107
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Zou Jianhua,Ma Xiaoqiong,Zhang Guangji,Shen Li,Zhou Liting,Yu Yu,Zhu Fanfan,Chen Zhe

Funder

Zhejiang Provincial Natural Science Foundation of China

Special Foundation of Science Technology Department of Zhejiang Province

Specialized Research Fund for the Doctoral Program of Higher Education

Guangji Zhang

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference44 articles.

1. Arsenical-based cancer drugs

2. Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer

3. Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway

4. Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

5. Arsenic Compounds in the Treatment of Multiple Myeloma: A New Role for a Historical Remedy

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and prognostic role of sphingosine 1-phosphate receptor 4 (S1PR4) as a biomarker of skin cutaneous melanoma;Heliyon;2024-03

2. Development of a single mobile phase for LC-IM-MS-based discovery lipidomics and metabolic phenotyping: Application to methapyrilene hepatotoxicity in the rat;Journal of Chromatography A;2024-01

3. Assessment of plasma amino acids, purines, tricarboxylic acid cycle metabolites, and lipids levels in NSCLC patients based on LC-MS/MS quantification;Journal of Pharmaceutical and Biomedical Analysis;2022-11

4. Arsenic trioxide inhibits the activity of SphK1 by decreasing the level of phosphatidylserine and phosphatidic acid in the human gastric cancer cell line MGC-803;BIOCELL;2022

5. Arsenic trioxide inhibits the activity of SphK1 by decreasing the level of phosphatidylserine and phosphatidic acid in the human gastric cancer cell line MGC-803;BIOCELL;2022